2. Thank you for taking the preassessment
Thank you for taking the preassessment. (Note: the questions were developed by an independent consulting group with expertise in assessing the effectiveness of medical education.) To assess learning, these questions will be repeated at the end of the activity.

3. Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

7. “Pleiotropic” Non-BP-Lowering Effects of Renal Denervation

8. ALSTER BP Registry: Efficacy and Safety of Redo Renal Denervation in Nonresponders

9. Renal Artery Stenosis After Renal Denervation

10. Case Reports of Renal Artery Stenosis After Renal Denervation

11. Symplicity HTN-1: eGFR Stable So Far

12. Urinary Albumin Excretion

13. EnligHTN First in Man: Renal Function

14. Surrogates of Vascular Stiffness Reduced With Renal Denervation

15. Small Reductions in BP Lower Stroke/IHD Mortality

16. EnligHTNment Trial (Design Not Finalized)

17. European Society of Cardiology Consensus: Eligibility

18. Multidisciplinary Team Considerations

19. Avoid RDN in Stented Renal Arteries

21. Symplicity Spyral First in Man

22. Symplicty Global Registry (149 Sites)

23. Abbreviations

24. References

25. References (cont)

26. References (cont)

27. References (cont)

28. References (cont)